{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:03:38Z","timestamp":1788314618578,"version":"build-2803163510"},"reference-count":88,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Radiation Oncology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.semradonc.2011.05.003","type":"journal-article","created":{"date-parts":[[2011,9,20]],"date-time":"2011-09-20T09:38:13Z","timestamp":1316511493000},"page":"256-263","source":"Crossref","is-referenced-by-count":180,"title":["Hepatic Radiation Toxicity: Avoidance and Amelioration"],"prefix":"10.1016","volume":"21","author":[{"given":"Chandan","family":"Guha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Kavanagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semradonc.2011.05.003_bib1","first-page":"200","article-title":"Radiation hepatitis","volume":"93","author":"Ingold","year":"1965","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"10.1016\/j.semradonc.2011.05.003_bib2","first-page":"597","article-title":"The human liver after radiation injury","volume":"48","author":"Reed","year":"1966","journal-title":"Am J Pathol"},{"key":"10.1016\/j.semradonc.2011.05.003_bib3","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.ijrobp.2008.07.032","article-title":"Microscopic and macroscopic tumor and parenchymal effects of liver stereotactic body radiotherapy","volume":"73","author":"Olsen","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2011.05.003_bib4","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0360-3016(94)00418-K","article-title":"Hepatic toxicity resulting from cancer treatment","volume":"31","author":"Lawrence","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2011.05.003_bib5","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ijrobp.2005.12.031","article-title":"Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: The risk factors and hepatic radiation tolerance","volume":"65","author":"Liang","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2011.05.003_bib6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijrobp.2005.11.034","article-title":"Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma","volume":"65","author":"Xu","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2011.05.003_bib7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0360-3016(02)02915-2","article-title":"Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: Dosimetric analysis and implication","volume":"54","author":"Cheng","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2011.05.003_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0268-960X(03)00002-X","article-title":"Veno-occlusive disease: Cytokines, genetics, and haemostasis","volume":"17","author":"Coppell","year":"2003","journal-title":"Blood Rev"},{"key":"10.1016\/j.semradonc.2011.05.003_bib9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","article-title":"Hepatic veno-occlusive disease following stem cell transplantation: Incidence, clinical course, and outcome","volume":"16","author":"Coppell","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.semradonc.2011.05.003_bib10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00062752-200311000-00010","article-title":"Hepatic veno-occlusive disease: Pathogenesis, diagnosis and treatment","volume":"10","author":"Wadleigh","year":"2003","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.semradonc.2011.05.003_bib11","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/sj.bmt.1700760","article-title":"Changes in hemostatic parameters in hepatic veno-occlusive disease following bone marrow transplantation","volume":"19","author":"Park","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.semradonc.2011.05.003_bib12","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semradonc.2011.05.003_bib13","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1056\/NEJMe0802241","article-title":"Sorafenib in liver cancer\u2014Just the beginning","volume":"359","author":"Roberts","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semradonc.2011.05.003_bib14","doi-asserted-by":"crossref","DOI":"10.1007\/s12029-010-9194-4","article-title":"Sorafenib and radiation therapy for the treatment of advanced hepatocellular carcinoma","author":"Horgan","year":"2010","journal-title":"J Gastrointest Cancer"},{"key":"10.1016\/j.semradonc.2011.05.003_bib15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2165\/0044011-200929010-00007","article-title":"Combination of sorafenib and intensity modulated radiotherapy for unresectable hepatocellular carcinoma","volume":"29","author":"Hsieh","year":"2009","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.semradonc.2011.05.003_bib16","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijrobp.2009.07.1725","article-title":"Angiogenic blockade and radiotherapy in hepatocellular carcinoma","volume":"78","author":"Chi","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"suppl","key":"10.1016\/j.semradonc.2011.05.003_bib17","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.ijrobp.2009.06.092","article-title":"Radiation-associated liver injury","volume":"76","author":"Pan","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2011.05.003_bib18","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/hep.21563","article-title":"The model for end-stage liver disease (MELD)","volume":"45","author":"Kamath","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.semradonc.2011.05.003_bib19","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.semradonc.2011.05.003_bib20","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa0801209","article-title":"Hyponatremia and mortality among patients on the liver-transplant waiting list","volume":"359","author":"Kim","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semradonc.2011.05.003_bib21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/MOG.0b013e32833867d8","article-title":"Organ allocation for chronic liver disease: Model for end-stage liver disease and beyond","volume":"26","author":"Asrani","year":"2010","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.semradonc.2011.05.003_bib22","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.dld.2008.01.015","article-title":"The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: A prospective survey","volume":"40","author":"Huo","year":"2008","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.semradonc.2011.05.003_bib23","first-page":"584","article-title":"Pathogenesis of veno-occlusive liver disease after radiation","volume":"104","author":"Fajardo","year":"1980","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.semradonc.2011.05.003_bib24","first-page":"240","article-title":"Hepatic injury following irradiation\u2014A morphologic study","volume":"43","author":"Ogata","year":"1963","journal-title":"Tokushima J Exp Med"},{"key":"10.1016\/j.semradonc.2011.05.003_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2002-23204","article-title":"Toxic injury to hepatic sinusoids: Sinusoidal obstruction syndrome (veno-occlusive disease)","volume":"22","author":"DeLeve","year":"2002","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.semradonc.2011.05.003_bib26","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/0016-5085(80)90911-7","article-title":"An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation","volume":"79","author":"Shulman","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semradonc.2011.05.003_bib27","first-page":"549","article-title":"Hepatic veno-occlusive disease after bone marrow transplantation","volume":"127","author":"Shulman","year":"1987","journal-title":"Am J Pathol"},{"key":"10.1016\/j.semradonc.2011.05.003_bib28","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/hep.1840190515","article-title":"Veno-occlusive disease of the liver after marrow transplantation: Histological correlates of clinical signs and symptoms","volume":"19","author":"Shulman","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.semradonc.2011.05.003_bib29","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/hep.510260117","article-title":"Severe radiation-induced liver disease following localized radiation therapy for biliopancreatic carcinoma: Activation of hepatic stellate cells as an early event","volume":"26","author":"Sempoux","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.semradonc.2011.05.003_bib30","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semradonc.2011.05.003_bib31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol Rev"},{"key":"10.1016\/j.semradonc.2011.05.003_bib32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2307\/3577586","article-title":"Transforming growth factor-beta 1 expression in irradiated liver","volume":"122","author":"Anscher","year":"1990","journal-title":"Radiat Res"},{"key":"10.1016\/j.semradonc.2011.05.003_bib33","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1056\/NEJM199306033282203","article-title":"Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer","volume":"328","author":"Anscher","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semradonc.2011.05.003_bib34","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.ijrobp.2004.05.048","article-title":"Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease","volume":"60","author":"Cheng","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2011.05.003_bib35","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1158\/1078-0432.CCR-06-2459","article-title":"Radiation-induced hepatitis B virus reactivation in liver mediated by the bystander effect from irradiated endothelial cells","volume":"13","author":"Chou","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.semradonc.2011.05.003_bib36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","article-title":"Tolerance of normal tissue to therapeutic irradiation","volume":"21","author":"Emami","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2011.05.003_bib37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0360-3016(93)90428-X","article-title":"Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: Results of the RTOG dose escalating protocol","volume":"27","author":"Russell","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2011.05.003_bib38","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/PPO.0b013e3181d7e8cf","article-title":"Radioembolization (yttrium-90 microspheres) for primary and metastatic hepatic malignancies","volume":"16","author":"Kennedy","year":"2010","journal-title":"Cancer J"},{"key":"10.1016\/j.semradonc.2011.05.003_bib39","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.2967\/jnumed.110.075861","article-title":"Efficacy and toxicity related to treatment of hepatocellular carcinoma with 90Y\u2013SIR spheres: Radiobiologic considerations","volume":"51","author":"Strigari","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.semradonc.2011.05.003_bib40","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0039-6109(02)00051-8","article-title":"Colorectal metastasis (liver and lung)","volume":"82","author":"Penna","year":"2002","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.semradonc.2011.05.003_bib41","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0360-3016(02)02846-8","article-title":"Analysis of radiation-induced liver disease using the Lyman NTCP model","volume":"53","author":"Dawson","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2011.05.003_bib42","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1002\/cncr.21012","article-title":"Hypofractionated three-dimensional conformal radiation therapy for primary liver carcinoma","volume":"103","author":"Liang","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2011.05.003_bib43","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00066-006-1564-2","article-title":"Proton beam therapy for hepatocellular carcinoma patients with severe cirrhosis","volume":"182","author":"Hata","year":"2006","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.semradonc.2011.05.003_bib44","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.ijrobp.2005.01.002","article-title":"A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases","volume":"62","author":"Schefter","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2011.05.003_bib45","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ijrobp.2009.09.009","article-title":"Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: Dose-volumetric parameters predicting the hepatic complication","volume":"78","author":"Son","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2011.05.003_bib46","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.ijrobp.2007.10.059","article-title":"Universal survival curve and single fraction equivalent dose: Useful tools in understanding potency of ablative radiotherapy","volume":"70","author":"Park","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2011.05.003_bib47","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s12094-010-0492-x","article-title":"Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma","volume":"12","author":"Cardenes","year":"2010","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.semradonc.2011.05.003_bib48","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1046\/j.1365-2559.1999.00569.x","article-title":"Hepatic stellate cells (Ito cells) in veno-occlusive disease of the liver after allogeneic bone marrow transplantation","volume":"34","author":"Sato","year":"1999","journal-title":"Histopathology"},{"key":"10.1016\/j.semradonc.2011.05.003_bib49","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1182\/blood.V89.6.2184","article-title":"Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation","volume":"89","author":"Salat","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.semradonc.2011.05.003_bib50","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/sj.bmt.1702821","article-title":"Serum hyaluronic acid in patients with veno-occlusive disease following bone marrow transplantation","volume":"27","author":"Fried","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.semradonc.2011.05.003_bib51","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/hep.22573","article-title":"Hepatic irradiation augments engraftment of donor cells following hepatocyte transplantation","volume":"49","author":"Yamanouchi","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.semradonc.2011.05.003_bib52","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/0140-6736(93)91646-4","article-title":"Monitoring of veno-occlusive disease after bone marrow transplantation by serum aminopropeptide of type III procollagen","volume":"342","author":"Eltumi","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.semradonc.2011.05.003_bib53","first-page":"471","article-title":"N-terminal peptide of type III procollagen: A marker for the development of hepatic veno-occlusive disease after BMT and a basis for determining the timing of prophylactic heparin","volume":"11","author":"Rio","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.semradonc.2011.05.003_bib54","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.bmt.1701445","article-title":"Relevance of proteins C and S, antithrombin III, von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing allogeneic bone marrow transplantation: A prospective study","volume":"22","author":"Lee","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.semradonc.2011.05.003_bib55","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/sj.bmt.1703544","article-title":"Impaired activity of plasma von Willebrand factor-cleaving protease may predict the occurrence of hepatic veno-occlusive disease after stem cell transplantation","volume":"29","author":"Park","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.semradonc.2011.05.003_bib56","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2214\/ajr.135.3.445","article-title":"CT of radiation-induced hepatic injury","volume":"135","author":"Jeffrey","year":"1980","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.semradonc.2011.05.003_bib57","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00004728-198703000-00013","article-title":"CT and MR imaging of radiation hepatitis","volume":"11","author":"Unger","year":"1987","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.semradonc.2011.05.003_bib58","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2214\/ajr.165.1.7785638","article-title":"High-dose localized radiation therapy for treatment of hepatic malignant tumors: CT findings and their relation to radiation hepatitis","volume":"165","author":"Yamasaki","year":"1995","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.semradonc.2011.05.003_bib59","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0360-3016(03)00586-8","article-title":"Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors","volume":"57","author":"Herfarth","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2011.05.003_bib60","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1042\/CS20000080","article-title":"Non-invasive quantification of liver perfusion with dynamic computed tomography and a dual-input one-compartmental model","volume":"99","author":"Materne","year":"2000","journal-title":"Clin Sci Lond"},{"key":"10.1016\/j.semradonc.2011.05.003_bib61","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijrobp.2007.05.078","article-title":"Liver function after irradiation based on computed tomographic portal vein perfusion imaging","volume":"70","author":"Cao","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2011.05.003_bib62","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF02990026","article-title":"Comparison of Tc-99m-GSA scintigraphy with hepatic fibrosis and regeneration in patients with hepatectomy","volume":"17","author":"Iguchi","year":"2003","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.semradonc.2011.05.003_bib63","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1200\/JCO.2008.16.1893","article-title":"Sinusoidal obstructive syndrome diagnosed with superparamagnetic iron oxide-enhanced magnetic resonance imaging in patients with chemotherapy-treated colorectal liver metastases","volume":"26","author":"Ward","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2011.05.003_bib64","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/1097-0142(197901)43:1<174::AID-CNCR2820430126>3.0.CO;2-Q","article-title":"Anticoagulation and high dose liver radiation: A preliminary report","volume":"43","author":"Lightdale","year":"1979","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2011.05.003_bib65","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood.V89.5.1501","article-title":"Treatment of hepatic venocclusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients","volume":"89","author":"Bearman","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.semradonc.2011.05.003_bib66","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/hep.510240414","article-title":"Cellular target of cyclophosphamide toxicity in the murine liver: Role of glutathione and site of metabolic activation","volume":"24","author":"DeLeve","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.semradonc.2011.05.003_bib67","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1055\/s-2007-1007173","article-title":"Glutathione defense in non-parenchymal cells","volume":"18","author":"DeLeve","year":"1998","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.semradonc.2011.05.003_bib68","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/hep.510230326","article-title":"Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: The role of glutathione and relevance to hepatic venoocclusive disease","volume":"23","author":"DeLeve","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.semradonc.2011.05.003_bib69","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12011-009-8513-8","article-title":"Selenium and vitamin E modulates radiation-induced liver toxicity in pregnant and nonpregnant rat: Effects of colemanite and hematite shielding","volume":"135","author":"Gencel","year":"2010","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.semradonc.2011.05.003_bib70","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/00003495-199345020-00007","article-title":"Defibrotide","volume":"45","author":"Palmer","year":"1993","journal-title":"Drugs"},{"key":"10.1016\/j.semradonc.2011.05.003_bib71","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1006\/bbrc.1994.1539","article-title":"Isolation and identification of aptamers from defibrotide that act as thrombin antagonists in vitro","volume":"200","author":"Bracht","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.semradonc.2011.05.003_bib72","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1182\/blood-2008-04-149682","article-title":"Angiogenesis alteration by defibrotide: Implications for its mechanism of action in severe hepatic veno-occlusive disease","volume":"112","author":"Benimetskaya","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semradonc.2011.05.003_bib73","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood-2002-04-1216","article-title":"Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: Response without significant toxicity in a high-risk population and factors predictive of outcome","volume":"100","author":"Richardson","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.semradonc.2011.05.003_bib74","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.bbmt.2010.02.009","article-title":"Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: A multicenter, randomized, dose-finding trial","volume":"16","author":"Richardson","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"suppl","key":"10.1016\/j.semradonc.2011.05.003_bib75","doi-asserted-by":"crossref","first-page":"121S","DOI":"10.1097\/01.alc.0000189284.98684.22","article-title":"Anti-TGF-beta strategies for the treatment of chronic liver disease","volume":"29","author":"Breitkopf","year":"2005","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.semradonc.2011.05.003_bib76","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1096\/fasebj.13.13.1774","article-title":"Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: Down-regulation by cAMP","volume":"13","author":"Duncan","year":"1999","journal-title":"FASEB J"},{"key":"10.1016\/j.semradonc.2011.05.003_bib77","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/jcp.21449","article-title":"Neutralizing monoclonal antibody to human connective tissue growth factor ameliorates transforming growth factor-beta-induced mouse fibrosis","volume":"216","author":"Ikawa","year":"2008","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.semradonc.2011.05.003_bib78","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.2215\/CJN.09321209","article-title":"Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria","volume":"5","author":"Adler","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semradonc.2011.05.003_bib79","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/lt.21965","article-title":"Bone marrow-derived stem cells in liver repair: 10 Years down the line","volume":"16","author":"Gilchrist","year":"2010","journal-title":"Liver Transplant"},{"key":"10.1016\/j.semradonc.2011.05.003_bib80","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.biocel.2010.01.013","article-title":"Model systems and experimental conditions that lead to effective repopulation of the liver by transplanted cells","volume":"43","author":"Shafritz","year":"2011","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.semradonc.2011.05.003_bib81","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jhep.2010.05.010","article-title":"Barriers to the successful treatment of liver disease by hepatocyte transplantation","volume":"53","author":"Soltys","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.semradonc.2011.05.003_bib82","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/scrt22","article-title":"Human CD34+ cells mobilized by granulocyte colony-stimulating factor ameliorate radiation-induced liver damage in mice","volume":"1","author":"Li","year":"2010","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.semradonc.2011.05.003_bib83","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1582-4934.2009.00912.x","article-title":"Recruitment of endogenous bone marrow mesenchymal stem cells towards injured liver","volume":"14","author":"Chen","year":"2010","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.semradonc.2011.05.003_bib84","first-page":"5871","article-title":"Amelioration of radiation-induced liver damage in partially hepatectomized rats by hepatocyte transplantation","volume":"59","author":"Guha","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.semradonc.2011.05.003_bib85","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1172\/JCI43267","article-title":"Induced pluripotent stem cell-derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice","volume":"120","author":"Espejel","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semradonc.2011.05.003_bib86","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1172\/JCI44422","article-title":"From skin cells to hepatocytes: Advances in application of iPS cell technology","volume":"120","author":"Greenbaum","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semradonc.2011.05.003_bib87","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/MOG.0b013e32833a6bec","article-title":"Recent advances in liver stem cell therapy","volume":"26","author":"Kisseleva","year":"2010","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.semradonc.2011.05.003_bib88","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.23354","article-title":"Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells","volume":"51","author":"Si-Tayeb","year":"2010","journal-title":"Hepatology"}],"container-title":["Seminars in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429611000452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429611000452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T09:04:17Z","timestamp":1592989457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053429611000452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":88,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S1053429611000452"],"URL":"https:\/\/doi.org\/10.1016\/j.semradonc.2011.05.003","relation":{},"ISSN":["1053-4296"],"issn-type":[{"value":"1053-4296","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}